ARCHIVES

Strict System For Protection Of Human Subjects Ordered In Wake Of NIH Investigation

This article is from The Cancer Letter archive.

Vol. 17 No. 32 | August 9, 1991

Download PDF Visit The Full Archive

Related Articles

“Harm-Reduction” Products No Proven, IOM Report Says.

March 2, 2001

NCI Plans Progress Review In Lymphoma This Year.

March 10, 2000

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

April 25, 2014

Jill ElkenberryTo Get ACCC Award

March 17, 1989

Breslow Says NCI, Centers, States Should Collaborate On Cancer Control

June 1, 1984

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

April 28, 2006